Undifferentiated carcinoma with osteoclast-like giant cell (UCOGC) is a ductal carcinoma variant with a recently reported more protracted survival and pathognomonic histology comprising two cell populations: the mononuclear tumoral cells and nontumoral multinucleated giant cells. It usually presents as a large heterogenic tumor with mixed solid-cystic components. The tumor develops from the ductal epithelium but the sequence of epithelial changes is often not identified due to the rapid tumoral growth and associated necrotic changes. We report a case of a 76-year-old patient diagnosed with cephalic UCOGC originating in the epithelium of the main pancreatic duct with endoluminal growth and foci of other ductal neoplasms (high-grade pancreatic intraepithelial neoplasia (PanIN) and conventional ductal carcinoma). The particularity of our case consists in the identification of the columnar epithelium conversion, through high-grade PanIN, into UCOGC specific malignant features, in a large size tumor -aspect usually reported in small tumors. Alongside our case we also present a brief literature review of cephalic UCOGC case reports and case series.
Introduction
Undifferentiated carcinoma with osteoclast-like giant cell is a rare entity, firstly described in 1968 by Rosai [1] . This pathologic entity is reported in the mainstream under various terms: metaplastic/anaplastic carcinoma, osteoclastoma, or osteoclastic giant cell tumor [2-5].
The key element for diagnosis consists in the association of tumoral mononuclear cells with a variable number of non-tumoral multinucleated cells, osteoclast-like [6] . Summing less than 1% among malignant epithelial pancreatic proliferations [7] , the tumor has origin in the pancreatic ductal epithelium and a similar genic signature with ductal carcinoma [8] , but very different morphology and variable prognosis [9, 10] . Even if data about UCOGC are accumulating, there are still unexplained events in the tumor biology. Recent research addresses the role of osteoclast-like giant cells [5, 11] , the involvement of different pancreatic intraductal lesions, presumed as origin point [3, [12] [13] [14] , and the identification of the morphological alterations sequence leading from ductal epithelium to UCOGC [15] .
Therefore, we present a case of UCOGC associated with conventional ductal carcinoma, arising from the main pancreatic duct epithelium. By highlighting the main clinicopathological features, our report complements data already published on this topic and contributes to a better characterization of the tumor behavior.
Case report
We describe the case of a 76-year-old female presented at the Surgical Department of "Sf. Spiridon" County Emergency Hospital with a large palpable upper abdominal tumor. The patient reported right upper abdominal pain, nausea, vomiting, asthenia and weight loss during the last month. She also had a history of ischemic heart disease and chronic cardiac failure NYHA II. Physical examination revealed pale, not jaundiced, dehydrated skin, cachexia (BMI=16.5 kg/m), and a 12/10 cm mass located in epigastrium and right hypochondrium, mobile, firm and wellcircumscribed. Laboratory tests revealed moderate anemia (Hb=9.9 g/dL, Ht=31%), high levels of carbohydrate antigen 19-9 (CA 19-9 =194 U/mL; normal <33 U/mL) and C reactive protein (CRP=3.59 mg/L; normal <0.5 mg/L). Abdominal computed tomography ( Figure 1 ) revealed a heterogeneous tumor of 83/130/100 mm, predominantly cystic, belonging to the head of the pancreas, in close contact with the superior mesenteric vein and spleno-mesenteric vein (on a length of over 55 mm), narrowing the vessels without thrombosis; Wirsung duct was dilated (10 mm in diameter); peritumoral lymphadenopathies were noted. Due to the close contact of the tumor with the vascular components, and the patient's anaesthetic risk (ASA III), an exploratory laparotomy was first performed. This procedure showed a cephalic pancreatic tumor invasive into the antro-pyloric region of the stomach, without liver involvement; the lymph nodes were negative for tumoral cells on frozen section. The surgical team decided to continue the surgery with the Whipple procedure, removing the entire expansive process (Figure 2) . Gross examination of the surgical specimen revealed a 115/70 mm pancreatic mass, firm, relatively well-circumscribed, located in the cephalic zone with intraluminal extension into the dilated main pancreatic duct towards ampullary region; thus, the major duodenal papilla was still permeable. On cut section, the tumor appeared heterogeneous, with solid tan areas, low density brown-reddish areas and microcystic lesions.
Tissue samples were fixed in 10% formalin, embedded in paraffin blocks, sectioned at 4-μm thickness, and stained with Hematoxylin-eosin for light microscopy evaluation.
The pancreatic tissue samples presented a diffuse tumor proliferation composed mainly of large mononuclear pleomorphic cells, from round-ovoid to spindle-shaped, discohesive, with inconspicuous mitotic activity (1-2 mitosis/HPF), associated with numerous, diffusely spread multinucleated osteoclast-like giant cells, phagocitically active, and moderate desmoplastic stroma. The tumor growth patterns were pushing border, endoluminal/polypoid and infiltrative into the stroma (Figures 3-5) . Areas of tumor necrosis and hemorrhage were also identified. Areas of tumor necrosis and hemorrhage were also identified. The tumor proliferation originated into the main pancreatic duct and extended focally into the duodenal wall without muscular layer or gastric antrum involvement. The main pancreatic duct was dilated, focally with high grade dysplasia, associating foci of invasive ductal adenocarcinoma ( Figure 6 ).
The adjacent pancreatic parenchyma presented pancreatic intraepithelial neoplasia (PanIN low-grade and high-grade) and chronic pancreatitis foci (Figure 7) . The surgical resection margins and 16 lymph nodes were negative for tumor cells.
The histological aspects oriented towards an UCOGC associated with conventional pancreatic ductal carcinoma.
Further immunohistochemistry examination using monoclonal antibodies against cytokeratin (Dako, clone AE1/AE3, dilution 1:50), CD68 (Novocastra, clone 514H12, dilution 1:100) and Vimentin (Novocastra, clone V8, dilution 1:150) confirmed the diagnosis of UCOGC.
The multinucleated osteoclastic giant cells were strongly positive for CD68 and Vimentin, and negative for CK AE1/AE3, and the pleomorphic tumoral cells were positive for CK AE1/AE3 and Vimentin (Figures 8-10 ).
Due to favorable uneventful post-operatory evolution the patient was discharged on 9 th day with the diagnosis of stage IIA UCOGC (pT3N0M0 LV0Pn0), associated with invasive conventional pancreatic ductal carcinoma (5%). Unfortunately, the patient died 4 months after surgery, without any documented recurrent or metastatic neoplastic process. The awareness regarding UCOGC led to an increase of the number of published papers: from less than 50 cases between 1968 -2011 [11] to over 150 nowadays, including several studies performed on larger groups that also associate ultrastructural, molecular and genetic data.
However, the lack of consensus concerning the histopathological assessment, clinical course or surgical management is due to the relative rarity of this type of tumor [8, 9] . One of the main issues regards the originthe precise lineage of tumor components being a matter of debate. Three different hypotheses were formulated, sustaining either an epithelial origin, a mesenchymal origin or a common pluripotent progenitor which undergoes both epithelial and mesenchymal dedifferentiation [6, 17, 18] . Nowadays, the epithelial origin is the most widely accepted, based on the K-ras codon 12 mutation identified in the mononuclear tumor cells -that is one of the driver mutation also present in conventional pancreatic duct adenocarcinoma, and on the retained expression of epithelial markers (CK, EMA) -at least focally [19] . On the other hand, the vimentin expression in the mononuclear cells of this epithelial tumor sustains the epithelial-mesenchymal transition within the carcinogenic process [20] . However, the positive mesenchymal and epithelial markers could support the interconnection of these three theories.
Despite all this evidence, it is still unknown how the same genetic driver mutations and the same preneoplastic lesions as ductal carcinoma can lead to such different histological features. Most probably, the UCOGC pathogenic mechanism involves not only somatic mutations, but also other molecular events [8] .
The common clinical presentation of UCOGC is nonspecific and includes symptoms such as upper abdominal pain, jaundice, anorexia, steatorrhea, weight loss, anemia, elevated CA 19-9, CEA and CRP levels [21, 22] . Unusual presentation includes diabetes exacerbation, melena, impaired liver function or fatigue.
Gross evaluation usually reveals a cystic tumor with solid component, with large areas of necrosis commonly confined to the head of the pancreas. This situation can be associated with dilated main pancreatic duct, especially if the polypoid endoluminal growth pattern is present. It appears that 60% of the cases have intracystic/ductal prominent growth. The described nodular pushing border could represent ducts filled in by the tumoral process [9, 11, 13] .
Although the tumor grows rapidly -more than half of reported cases measuring over 10 cm at the time of the diagnosis, incidental small sized tumors or "in situ" lesion are documented [10, 15, 23, 24] .
The gold standard in diagnosis consists in the identification of the two cell populations, the pathognomonic element being the benignlooking multinucleated giant cells associated with mononuclear pleomorphic tumor cells. We also noted, in the nearby smaller branches of main pancreatic duct, the presence of intraepithelial neoplasia, low-and high-grade. Ductal intraepithelial neoplasia was described in a large number of cases, in some of them in direct connection with the UCOGC [24, 35] . The most frequent preneoplastic lesion associated with UCOGC is mucinous cystic neoplasm (MCN), followed by IPMN and PanIN, with at least some foci of high-grade dysplasia [9, 12] . Beside the classic pattern described, we also identified small cystic structures in the pancreatic parenchyma with a rim of UCOGC, which could be the result of intraductal neoplasia spread replacing ductal epithelium, similar to "cancerization of ducts" described in classic ductal carcinoma [36] . Osteoid change, vascular emboli, perineural invasion, and/or lymph node metastasis -histological features frequently present in the ductal pancreatic adenocarcinoma [9], were not found in our case.
The different scoring systems lead to difficulty in establishing the prognosis. Our case was assessed as low grade tumorgrade I, with abundant large osteoclast giant cells and background cells with minimal atypia and scant mitoses, in accordance with the histopathological grading based on the scoring system of Netherlands Committee on Bone Tumors [9], but also as grade 3 -poorly differentiated tumor by using the exocrine pancreatic carcinoma grading from WHO 2010 [16] and as grade 4 according to The American Joint Committee on Cancer staging manual 8 th edition [37] . These inadvertences require further studies to decide the usefulness of one score versus another.
The main clinical and pathology features of UCOGC present in the mainstream are summarized in Table 1 and Table 2 . The PubMed search was performed by using the key-words "anaplastic" and "pancreas" alongside "osteoclast-like giant cell" and "pancreas", due to the multiple synonyms for UCOGC. From a total of 321 articles, we eliminated all papers without English text available or describing tumors without osteoclast-like giant cells, and we obtained 61 items. These papers include 30 case reports with tail location, 17 case reports with cephalic location and 14 case series. Therefore, the rarity of this pathological entity, mainly at cephalic site, sustains the value of our paper.
The cephalic location overlaps with the general features of UCOGC described earlier, although we can identify a tendency to smaller lesions (10 cases under 5 cm). Early intraductal neoplasia with dysplastic epithelium and abrupt change of tumor phenotype was rarely registered. The intraductal growth included polypoid masses in the main pancreatic duct and branches or extruding through ampulla.
The review of the literature shows a significant number of cases (9 of 17) associated with ductal neoplasia, intraductal or invasive. From a "ductal variant" point of view, the split carcinogenic process of ductal carcinoma with PanIN origin in acinar cells and IPMN origin in ductal cells could also reflect in UCOGC carcinogenesis, explaining the heterogeneity and variability of tumor behavior. Moreover, the intraductal growth pattern which significantly overlaps with IPMN morphology could imply the IPMNductal/UCOGC tumoral transformation axis, although there are cases of IPMN coexisting with ductal carcinoma molecularly unrelated [38, 39] . The PanIN -ductal carcinoma sequence, presumed until recently as originating from ductal epithelium, has been recently stated as acinar -derived with achieved ductal features through acinarductal metaplasia [38] , which can also be caused by inflammation [40] . 
Conclusions
UCOGC is a rare ductal carcinoma variant with great heterogeneity which provide nonspecific symptoms and in shaping morphological landscape, with histogenesis still under debate. Our case report confirms the ductal epithelial origin, pointing out the similar carcinogenic process with ductal carcinoma (through PanIN) and an abrupt shift to undifferentiated carcinoma phenotype. The molecular changes which determine the sudden transition remain to be discovered, further studies being necessary.
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